Scientific article
Case report
OA Policy
English

Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa

Published inNature communications, vol. 14, no. 1, 3629
Errata
  • Published erratum : Köhler T, Luscher A, Falconnet L, Resch G, McBride R, Mai QA, Simonin JL, Chanson M, Maco B, Galiotto R, Riat A, Civic N, Docquier M, McCallin S, Chan B, van Delden C. Author Correction: Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa. Nat Commun. 2023 Jul 24;14(1):4443.
  • DOI : 10.1038/s41467-023-40202-3
  • PMID : 37488101
Publication date2023-06-27
First online date2023-06-27
Abstract

Bacteriophage therapy has been suggested as an alternative or complementary strategy for the treatment of multidrug resistant (MDR) bacterial infections. Here, we report the favourable clinical evolution of a 41-year-old male patient with a Kartagener syndrome complicated by a life-threatening chronic MDR Pseudomonas aeruginosa infection, who is treated successfully with iterative aerosolized phage treatments specifically directed against the patient’s isolate. We follow the longitudinal evolution of both phage and bacterial loads during and after phage administration in respiratory samples. Phage titres in consecutive sputum samples indicate in patient phage replication. Phenotypic analysis and whole genome sequencing of sequential bacterial isolates reveals a clonal, but phenotypically diverse population of hypermutator strains. The MDR phenotype in the collected isolates is multifactorial and mainly due to spontaneous chromosomal mutations. All isolates recovered after phage treatment remain phage susceptible. These results demonstrate that clinically significant improvement is achievable by personalised phage therapy even in the absence of complete eradication of P. aeruginosa lung colonization.

Citation (ISO format)
KOHLER, Thilo et al. Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa. In: Nature communications, 2023, vol. 14, n° 1, p. 3629. doi: 10.1038/s41467-023-39370-z
Main files (1)
Article (Published version)
Secondary files (6)
Updates (1)
Erratum
Identifiers
Additional URL for this publicationhttps://www.nature.com/articles/s41467-023-39370-z
Journal ISSN2041-1723
190views
70downloads

Technical informations

Creation10/10/2023 09:12:31
First validation14/02/2024 09:20:46
Update time13/01/2025 15:48:56
Status update13/01/2025 15:48:56
Last indexation13/01/2025 15:49:08
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack